Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

OBJECTIVE: To verify the hypothesis that in rheumatoid arthritis (RA), tumor necrosis factor alpha (TNFalpha) plays a critical role in regulating leukocyte trafficking and chemokine levels. METHODS: Ten patients with longstanding RA received a single 10 mg/kg infusion of anti-TNFalpha monoclonal ant...

Полное описание

Библиографические подробности
Главные авторы:	Taylor, P, Peters, A, Paleolog, E, Chapman, P, Elliott, M, McCloskey, R, Feldmann, M, Maini, R
Формат:	Journal article
Язык:	English
Опубликовано:	2000

Схожие документы

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
по: Paleolog, E, и др.
Опубликовано: (1998)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
по: Maini, R, и др.
Опубликовано: (1995)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
по: Davis, D, и др.
Опубликовано: (1997)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
по: Feldmann, M, и др.
Опубликовано: (1997)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
по: Paleolog, E, и др.
Опубликовано: (1996)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
по: Taylor, P, и др.
Опубликовано: (2001)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
по: Elliott, M, и др.
Опубликовано: (1995)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
по: Feldmann, M, и др.
Опубликовано: (1997)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
по: Brennan, F, и др.
Опубликовано: (1995)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
по: Taylor, P, и др.
Опубликовано: (1999)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
по: Maini, R, и др.
Опубликовано: (1994)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
по: Elliott, M, и др.
Опубликовано: (1993)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
по: Maini, R, и др.
Опубликовано: (1997)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
по: Elliott, M, и др.
Опубликовано: (1995)

Cytokine blockade in rheumatoid arthritis.
по: Feldmann, M, и др.
Опубликовано: (2001)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
по: Maini, R, и др.
Опубликовано: (1998)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
по: Feldmann, M, и др.
Опубликовано: (1994)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
по: Elliott, M, и др.
Опубликовано: (1994)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
по: Maini, R, и др.
Опубликовано: (1999)

TNF alpha as a therapeutic target in rheumatoid arthritis.
по: Feldmann, M, и др.
Опубликовано: (1994)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
по: Chu, C, и др.
Опубликовано: (1991)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
по: Maini, R, и др.
Опубликовано: (1994)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
по: Elliot, M, и др.
Опубликовано: (2008)

Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures.
по: Schmidt, E, и др.
Опубликовано: (2013)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
по: Feldmann, M, и др.
Опубликовано: (1995)

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.
по: Haworth, C, и др.
Опубликовано: (1991)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
по: Maini, R, и др.
Опубликовано: (1995)

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
по: Ulfgren, A, и др.
Опубликовано: (2000)

TNF alpha--a pivotal role in rheumatoid arthritis?
по: Brennan, F, и др.
Опубликовано: (1992)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
по: Williams, R, и др.
Опубликовано: (2000)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
по: Buchan, G, и др.
Опубликовано: (1988)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
по: Deleuran, B, и др.
Опубликовано: (1992)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
по: Feldmann, M
Опубликовано: (1996)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
по: Feldmann, M, и др.
Опубликовано: (2001)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
по: Feldmann, M, и др.
Опубликовано: (2001)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
по: Feldmann, M, и др.
Опубликовано: (2002)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
по: Maini, R, и др.
Опубликовано: (1993)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
по: Elliott, M, и др.
Опубликовано: (1994)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
по: Feldmann, M, и др.
Опубликовано: (1995)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
по: Brennan, F, и др.
Опубликовано: (1997)